| Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ... New England Journal of Medicine 378 (8), 731-739, 2018 | 2501 | 2018 |
| Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials DS Hong, SG DuBois, S Kummar, AF Farago, CM Albert, KS Rohrberg, ... The Lancet Oncology 21 (4), 531-540, 2020 | 786 | 2020 |
| Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study TW Laetsch, SG DuBois, L Mascarenhas, B Turpin, N Federman, ... The Lancet Oncology 19 (5), 705-714, 2018 | 508 | 2018 |
| Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort S Smeland, SS Bielack, J Whelan, M Bernstein, P Hogendoorn, MD Krailo, ... European journal of cancer 109, 36-50, 2019 | 474 | 2019 |
| Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group S Bhatia, W Landier, M Shangguan, L Hageman, AN Schaible, AR Carter, ... Journal of Clinical Oncology 30 (17), 2094, 2012 | 353 | 2012 |
| Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: a report from the Children's Oncology Group PJ Leavey, L Mascarenhas, N Marina, Z Chen, M Krailo, J Miser, K Brown, ... Pediatric blood & cancer 51 (3), 334-338, 2008 | 212 | 2008 |
| Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma LE Davis, V Bolejack, CW Ryan, KN Ganjoo, ET Loggers, S Chawla, ... Journal of Clinical Oncology 37 (16), 1424, 2019 | 210 | 2019 |
| Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the … DS Hawkins, YY Chi, JR Anderson, J Tian, CAS Arndt, L Bomgaars, ... Journal of Clinical Oncology 36 (27), 2770, 2018 | 148 | 2018 |
| Systemic exposure to thiopurines and risk of relapse in children with acute lymphoblastic leukemia: a Children’s Oncology Group Study S Bhatia, W Landier, L Hageman, Y Chen, H Kim, CL Sun, N Kornegay, ... JAMA oncology 1 (3), 287-295, 2015 | 144 | 2015 |
| Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage–colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to … R Stripecke, AA Cardoso, KA Pepper, DC Skelton, XJ Yu, L Mascarenhas, ... Blood, The Journal of the American Society of Hematology 96 (4), 1317-1326, 2000 | 137 | 2000 |
| The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas SG DuBois, TW Laetsch, N Federman, BK Turpin, CM Albert, ... Cancer 124 (21), 4241-4247, 2018 | 130 | 2018 |
| Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's … L Mascarenhas, ER Lyden, PP Breitfeld, DO Walterhouse, SS Donaldson, ... Journal of clinical oncology 28 (30), 4658, 2010 | 128 | 2010 |
| Randomized phase II trial of bevacizumab or temsirolimus in combination with chemotherapy for first relapse rhabdomyosarcoma: a report from the Children’s Oncology Group L Mascarenhas, YY Chi, P Hingorani, JR Anderson, ER Lyden, ... Journal of clinical oncology 37 (31), 2866, 2019 | 101 | 2019 |
| Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group DS Shulman, K Klega, A Imamovic-Tuco, A Clapp, A Nag, AR Thorner, ... British journal of cancer 119 (5), 615-621, 2018 | 97 | 2018 |
| Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience CE Madigan, SH Armenian, MH Malogolowkin, L Mascarenhas Cancer 110 (9), 2061-2066, 2007 | 85 | 2007 |
| Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors SH Armenian, SK Gelehrter, T Vase, R Venkatramani, W Landier, ... Clinical Cancer Research 20 (24), 6314-6323, 2014 | 75 | 2014 |
| Sarcomas JH HaDuong, AA Martin, SX Skapek, L Mascarenhas Pediatric Clinics 62 (1), 179-200, 2015 | 71 | 2015 |
| Expanding the spectrum of dicer1-associated sarcomas M Warren, MC Hiemenz, R Schmidt, J Shows, J Cotter, S Toll, DM Parham, ... Modern Pathology 33 (1), 164-174, 2020 | 64 | 2020 |
| Gene delivery to human B-precursor acute lymphoblastic leukemia cells L Mascarenhas, R Stripecke, SS Case, D Xu, KI Weinberg, DB Kohn Blood, The Journal of the American Society of Hematology 92 (10), 3537-3545, 1998 | 60 | 1998 |
| Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma H Imran, F Enders, M Krailo, F Sim, S Okuno, D Hawkins, J Neglia, ... JBJS 91 (3), 604-612, 2009 | 59 | 2009 |
Rajkumar VenkatramaniBaylor College of MedicineVerified email at bcm.edu
